Omid Farokhzad

Omid C.
Farokhzad was the founder of DNIB Unwind, Inc. founded in 2006, serving as Director from 2006 to 2014.
Dr. Farokhzad was the founder of Selecta Biosciences, Inc. founded in 2007, serving as Chairman from 2018 to 2019.
Dr. Farokhzad was the founder of Tarveda Therapeutics, Inc. founded in 2011, serving as Director from 2011 to 2019.
Dr. Farokhzad is the founder of Seer, Inc. (California) founded in 2017, serving as Chairman & Chief Executive Officer since 2023.
Dr. Farokhzad is the founder of PrognomIQ, Inc. founded in 2020, serving as Chairman since 2020.
Dr. Farokhzad is also the founder of Semaphore, Inc.,Xlink Therapeutics, Inc...
Dr. Farokhzad is currently Director at Placon Therapeutics, Inc. Dr. Farokhzad is currently Director at Xira Connect, Inc. since 2019.
Dr. Farokhzad was Executive Chairman at Dynamics Special Purpose Corp.
from 2021 to 2022.
Dr. Farokhzad was Director-Center for Nanomedicine at The Brigham & Women's Hospital, Inc. from 2004 to 2017.
Dr. Farokhzad was Independent Director at Senti Biosciences, Inc. from 2022 to 2024.
Dr. Farokhzad was Professor at Harvard Medical School from 2004 to 2018.
Dr. Farokhzad earned an MBA from MIT Sloan School of Management.
Dr. Farokhzad earned graduate and doctorate degrees from Boston University School of Medicine.